Online inquiry

IVTScrip™ mRNA-Human ARFGAP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28570MR)

This product GTTS-WK28570MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARFGAP2 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001242832.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 84364
UniProt ID Q8N6H7
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARFGAP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28570MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK14901MR IVTScrip™ mRNA-Human ANKRD13D, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD13D
GTTS-WK18027MR IVTScrip™ mRNA-Human AHSA2, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA AHSA2
GTTS-WK27111MR IVTScrip™ mRNA-Human ARHGEF18, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF18
GTTS-WK11030MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK4041MR IVTScrip™ mRNA-Human CTNNB1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA CTNNB1
GTTS-WK23506MR IVTScrip™ mRNA-Human ARHGEF1, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF1
GTTS-WK13130MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK28356MR IVTScrip™ mRNA-Human ARMC5, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARMC5
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW